Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Emilie Johanning Bari"'
Autor:
Amalie R. Lanng, David S. Mathiesen, Mikkel B. Christensen, Mette M. Rosenkilde, Lærke S. Gasbjerg, Filip K. Knop, Signe Stensen, Emilie Johanning Bari, Bjørn Hoe, Bolette Hartmann, Jens J. Holst
Publikováno v:
Diabetes, Obesity and Metabolism. 23:68-74
The glucose-dependent insulinotropic polypeptide (GIP) fragment GIP(3-30)NH2 is a selective, competitive GIP receptor antagonist, and doses of 800 to 1200 pmol/kg/min inhibit GIP-induced potentiation of glucose-stimulated insulin secretion by >80% in
Publikováno v:
Diabetes, obesitymetabolismREFERENCES. 23(11)
To present an overview of exendin(9-39)NHWe systematically searched the literature on exendin(9-39)NHExendin(9-39)NHExendin(9-39)NH
Publikováno v:
Gasbjerg, L S, Bari, E J, Christensen, M & Knop, F K 2021, ' Exendin(9-39)NH2 : Recommendations for clinical use based on a systematic literature review ', Diabetes, Obesity and Metabolism, vol. 23, no. 11, pp. 2419-2436 . https://doi.org/10.1111/dom.14507
The glucagon-like peptide 1 (GLP-1) receptor antagonist exendin(9-39)NH2 has facilitated the description of GLP-1 physiology and the development of GLP-1 receptor agonists for the treatment of obesity and type 2 diabetes. As GLP-1 physiology continue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e763a5e1f5a805aac544da34880b820c
https://curis.ku.dk/portal/da/publications/exendin939nh2(4b0765a1-8fa4-4579-a022-1897e8ec10e6).html
https://curis.ku.dk/portal/da/publications/exendin939nh2(4b0765a1-8fa4-4579-a022-1897e8ec10e6).html
Autor:
Jens J. Holst, David S. Mathiesen, Bolette Hartmann, Mette M. Rosenkilde, Signe Stensen, Amalie R. Lanng, Lærke S. Gasbjerg, Emilie Johanning Bari, Mikkel Christensen, Filip K. Knop, Bjørn Hoe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7e9421e4042306d1b04e1bc37916cff
https://doi.org/10.1111/dom.14186/v2/response1
https://doi.org/10.1111/dom.14186/v2/response1